The dawn phenomenon across the glycemic continuum: Implications for defining dysglycemia

Cheng Li,Xiaojing Ma,Jun Yin,Yifei Mo,Lei Zhang,Jingyi Lu,Wei Lu,Yuqian Bao,Robert A Vigersky,Jian Zhou,Weiping Jia,Robert A. Vigersky
DOI: https://doi.org/10.1016/j.diabres.2020.108308
IF: 8.18
2020-08-01
Diabetes Research and Clinical Practice
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Aims</h3><p>To investigate the frequency of dawn phenomenon (DP) and its relationship with time in range (TIR) and glycemic variability (GV) using continuous glucose monitoring (CGM).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>781 subjects of a multicenter CGM study in China were included: those with normal glucose tolerance (NGT <em>n</em>=360); impaired glucose regulation (IGR <em>n</em>=173); newly diagnosed type 2 diabetes mellitus (T2D <em>n</em>=248). Analysis of the magnitude of DP (ΔG) was conducted with the primary definition of 1.11 mmol/L and a secondary definition of 0.56 mmol/L.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>The frequency of DP was 8.9%, 30.1% and 52.4% in NGT, IGR and T2D group, respectively, using the primary definition. In all three groups, TIR was lower (all <em>P</em>&lt;0.05), coefficient of variation (CV) was higher in DP subgroup (all <em>P</em>&lt;0.05). In DP subgroup of T2D, TIR was 7.0% (1.68h) lower and CV was 3.0% higher, and HbA<sub>1c</sub> was 0.6% (7 mmol/mol) higher using the primary definition (all <em>P</em>&lt;0.05).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>DP was present in a high percent of subjects with NGT and IGR. In newly diagnosed T2D group, the presence of DP was associated with poorer overall glycemic control.</p>
endocrinology & metabolism
What problem does this paper attempt to address?